Dogwood Therapeutics, Inc. (DWTX)
1.69
-0.03
(-1.74%)
USD |
NASDAQ |
Sep 18, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Dogwood Therapeutics Shareholders Equity (Quarterly) : 68.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.37M |
| March 31, 2026 | 80.62M |
| December 31, 2025 | 74.90M |
| September 30, 2025 | 77.39M |
| June 30, 2025 | 82.54M |
| March 31, 2025 | 7.087M |
| December 31, 2024 | -10.12M |
| September 30, 2024 | 0.9494M |
| June 30, 2024 | 3.136M |
| March 31, 2024 | 2.654M |
| December 31, 2023 | 3.807M |
| September 30, 2023 | 4.762M |
| June 30, 2023 | 4.692M |
| Date | Value |
|---|---|
| March 31, 2023 | 5.971M |
| December 31, 2022 | 7.326M |
| September 30, 2022 | 9.225M |
| June 30, 2022 | 7.142M |
| March 31, 2022 | 10.67M |
| December 31, 2021 | 14.50M |
| September 30, 2021 | 18.88M |
| June 30, 2021 | 22.86M |
| March 31, 2021 | 27.11M |
| December 31, 2020 | 29.94M |
| September 30, 2020 | -21.46M |
| June 30, 2020 | -18.74M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.50M |
| Total Liabilities (Quarterly) | 12.13M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 3.894 |
| Net Debt Paydown Yield | 27.97% |